2019
DOI: 10.1053/j.jvca.2018.09.029
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative Medication Management in Adult Cardiac Surgery: The 2017 European Association for Cardio-Thoracic Surgery Guidelines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 31 publications
0
3
0
1
Order By: Relevance
“…190 Moreover, safety concerns, or at least the practical issues related to the timing of insertion/removal of the catheter, may be exacerbated in the current era in which an aggressive antithrombotic regimen (eg, with early postoperative dual-antiplatelet therapy) is increasingly recommended in the perioperative period. 14 The use of peripheral nerve blocks, such as ultrasoundguided paravertebral block or erector spinae plane block, 197,198 as an alternative to central neuraxial techniques for multimodal anesthesia/analgesia in cardiac surgery, could carry fewer safety issues and is a potential area of future interest within the research field investigating the effect of anesthesia on postoperative outcomes, particularly in consideration of the emerging minimally invasive (eg, thoracotomy) cardiac surgery techniques.…”
Section: Effect On Outcomes Of Neuraxial Anesthesia/analgesia As An Amentioning
confidence: 99%
See 1 more Smart Citation
“…190 Moreover, safety concerns, or at least the practical issues related to the timing of insertion/removal of the catheter, may be exacerbated in the current era in which an aggressive antithrombotic regimen (eg, with early postoperative dual-antiplatelet therapy) is increasingly recommended in the perioperative period. 14 The use of peripheral nerve blocks, such as ultrasoundguided paravertebral block or erector spinae plane block, 197,198 as an alternative to central neuraxial techniques for multimodal anesthesia/analgesia in cardiac surgery, could carry fewer safety issues and is a potential area of future interest within the research field investigating the effect of anesthesia on postoperative outcomes, particularly in consideration of the emerging minimally invasive (eg, thoracotomy) cardiac surgery techniques.…”
Section: Effect On Outcomes Of Neuraxial Anesthesia/analgesia As An Amentioning
confidence: 99%
“…[11][12][13] However, there is growing evidence that also optimizing perioperative care may improve outcomes significantly. 2,14 The potential role of anesthesia (and of the anesthesiologist) in influencing outcome, particularly mortality, after cardiac surgery has been suggested since the mid-1980s. 15 Although the results of recent investigations 12,13 may lead to the opposite, and simplistic, conclusion that "the anesthesiologist makes no difference," there are plenty of reasons for the inability of such investigations to highlight a difference in outcome according to the individual attending cardiac anesthesiologist.…”
mentioning
confidence: 99%
“…Систематизировали и проанализировали следующие данные: возраст, пол, рост, масса тела, скорость клубочковой фильтрации, фракция изгнания левого желудочка, недавний прием антиагрегантов [25], плохая мобильность и тяжесть предоперационного состояния пациентов (согласно критериям E-CABG [26] Методы статистического анализа. Для каждого пациента рассчитали значение номограммы М (табл.…”
Section: материал и методыunclassified
“…5,6,[9][10][11][12] A lack of clear medication guidelines leaves treatment decisions up to clinical experience, findings from small observational studies, and extrapolation from adult data rather than relying on robust clinical trial evidence. 13,14 This exponentiates variation in post-operative medical management, and the lack of definitive data to support medication use puts children at risk for adverse events and denies them potential therapeutic benefits. [15][16][17] Clear medication guidelines may help minimise practice variation and ultimately improve the quality of care these children receive.Drug trials in critically ill infants and children with CHD are challenging due to a limited number of eligible patients and the need to address substantial pathophysiologic and age-related variability in drug disposition, efficacy, and safety.…”
mentioning
confidence: 99%